It has been reported that PCa patients with BRCA1/2 mutations can be treated with radiotherapy, cisplatin, anthracyclines, or poly (ADP-ribose) polymerase inhibitors (22, 23). Here, BRCA1 is linked to posterior cortical atrophy.